News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Identification of New Biomarker for Alzheimer’s Could Set Stage for Clinical Laboratory Test to Identify and Diagnosis the Disease in Its Early Stages

Initial skin test research shows promise but larger clinical studies needed before diagnostic tool could be ready for use by medical laboratories and pathologists

Researchers in Mexico developed a skin test that could lead to the early diagnosis of Alzheimer’s disease and pave the way for new therapies to treat a disease ranked as the sixth leading cause of death in the United States.

For clinical pathologists and medical laboratories, a testing breakthrough would be significant since the Alzheimer’s Association predicts that the number of Americans 65 and older with Alzheimer’s disease will reach 7.1 million by 2025, a 40% increase from today. (more…)

;